ArticleJCI insight2020

Pharmacologic and genetic approaches define human pancreatic β cell mitogenic targets of DYRK1A inhibitors.

Courtney Ackeifi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.